What's Going On With Weed Stocks Canopy Growth, Aurora Cannabis And Tilray?
Portfolio Pulse from Erica Kollmann
Cannabis stocks Canopy Growth Corporation (CGC), Aurora Cannabis, Inc. (ACB), and Tilray Brands, Inc. (TLRY) experienced a decline Wednesday after a brief rally due to reports that the DEA will reschedule marijuana. The stocks surged following the DEA's proposal to reclassify marijuana from a Schedule I to a Schedule III substance, indicating recognized medical uses and lower abuse potential. However, the proposal is pending review and public comment. CGC, ACB, and TLRY stocks are down significantly from Tuesday's highs.
May 01, 2024 | 4:44 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Aurora Cannabis shares gained over 25% after the DEA's announcement but are trading down more than 20% Wednesday.
ACB's stock movement is a direct response to the DEA's rescheduling proposal, reflecting the market's sensitivity to regulatory news affecting the cannabis industry.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Canopy Growth Corporation shares surged over 75% Tuesday but fell nearly 30% Wednesday after the DEA's proposal to reschedule marijuana.
The sharp increase followed by a significant drop in CGC's stock price is directly related to the DEA's proposal to reschedule marijuana, impacting investor sentiment and stock volatility.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Tilray Brands shares rose nearly 40% Tuesday but saw a 20% decrease Wednesday following the DEA's rescheduling proposal.
TLRY's stock experienced volatility due to the DEA's announcement on marijuana rescheduling, highlighting the impact of regulatory actions on cannabis stocks.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100